Health

Results: 325-336 of 9175

Hengrui Pharma Presents More Than 90 Oncology Studies at ASCO 2026, Highlighting Progress Across Multiple Tumor Types

Haleon Health Ambassador on motorbike, equipped with testing kits, samples and diagnostic tools

Haleon Invests in India to Deliver Better Everyday Health to Rural Communities

Diabetology’s Breakthrough Clinical Data From Oraglutide™ Oral GLP-1

PR Newswire associated0

Angel Yeast Showcases Yeast-Based Innovations for Animal Nutrition at TUYEM 2026

Business Wire logo

Cardiolife Partners with Bhutan Ministry of Health to Strengthen Nationwide Cardiac Care

Curasight Announces Preliminary Readout from its Phase 1 Clinical Trial with uTREAT® in Aggressive Brain Cancer (Glioblastoma)

Business Wire logo

Cosylab Launches PlanOne™ Treatment Planning System for Particle Therapy

PR Newswire associated0

Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)

People with type 2 diabetes who were increased to semaglutide 2 mg were as likely to achieve an HbA1c less than 7% and more likely to achieve greater than 5% weight loss than those who were switched to tirzepatide, in real-world data

Business Wire logo

Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference

Business Wire logo

LivaNova Appoints Anne Liddy as Chief Legal Officer

K Pro, Owkin's AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making.

Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi